Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Energy metabolism: An emerging therapeutic frontier in liver fibrosis
Iram Irshad; Saleh A Alqahtani; Kenichi Ikejima; Ming-Lung Yu; Manuel Romero-Gomez; Mohammed Eslam;
10.1016/j.aohep.2025.101896
Assessment of metabolic dysfunction-associated steatotic liver disease, alcohol-associated liver disease, and metabolic dysfunction and alcohol-associated steatotic liver disease in open Mexican population
Jorge Emilio Lira-Vera; Ángel Daniel Santana-Vargas; Gabriela Gutiérrez-Reyes; Oscar Morales-Gutiérrez; María de Fátima Higuera-de la Tijera; Diana Montemira-Orozco; Christian Hinojosa-Segura; Moisés Martínez-Castillo; Samantha Sánchez-Valle; María de los Ángeles Lemus-Peña; Daniel Montes de Oca-Ángeles; Abigail Hernández-Barragán; Marisela Hernández-Santillán; Yadira Lilian Béjar-Ramírez; José Luis Pérez-Hernández;
Ann Hepatol. 2026;31:
Aspartate aminotransferase¿to¿platelet ratio index (APRI) reliably excludes advanced fibrosis and cirrhosis in treated autoimmune hepatitis
Martine A.M.C. Baven-Pronk; Camiel J.M. Marijnissen; Maaike Biewenga; Albert F. Stättermayer; Maarten E. Tushuizen; Bart van Hoek;
Ann Hepatol. 2026;31: